Swiss medical watchdog orders Novartis’ Zelnorm/Zelmac market…
The News Review:
- Swiss medical watchdog orders Novartis’ Zelnorm/Zelmac market…
- man medical manufacturing unit could float within three years
- Makati Medical Center on road to financial health
- Ex-San Jose medical manager pleads guilty to stealing personal data.
Swiss medical watchdog orders Novartis’ Zelnorm/Zelmac market…
Forbes – May 31, 2007
‘Swissmedic has refused to extend the licence as the risks are greater than the benefit’ the Swiss medical authority said. The decision comes after a fresh analysis of the data from clinical studies revealed an increased risk of cardiovascular conditions Swissmedic said. In March this year Swissmedic already issued new administration recommendations after the FDA withdrew the drug from the market. Following US market withdrawal Novartis (nyse:.
man medical manufacturing unit could float within three years
Al-Bawaba – May 31, 2007
(SMSMCo) launched earlier this month could apply for its initial public offering (IP) within three years. The US-based company which launched the US $100 million Ascent Medical Technology Fund II a private equity vehicle to promote the development of the medical technology industry in the Middle East in 2005 is already confident of success with its man operations.
Makati Medical Center on road to financial health
Inquirer.net – May 31, 2007
the operator of the Makati Medical Center the hospital in the country’s top business district is on track to full financial recovery after sealing an agreement with banks to restructure P1. 2 billion in loans a company official said.
Ex-San Jose medical manager pleads guilty to stealing personal data.
Free with registration – San Jose Mercury News – AccessMyLibrary.com – May 31, 2007
Ex-San Jose medical manager pleads guilty to stealing personal data. (31-MAY-07) San Jose Mercury News (San Jose CA).
Written by admin on May 31st, 2007 with
no comments.
Read more articles on News.